The Study
Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.
This study looked at lots of big experiments where people were randomly assigned to take different things to lower bad cholesterol. It found that no matter how you lower cholesterol—whether with pills, diet, or surgery—the heart attack risk goes down about the same amount. So it’s not the pill itself that’s special—it’s the cholesterol going down.
Analysis score
Maximum 100 for a systematic review with meta-analysis.
Where the score came from
Scientists compared statins to diets and surgeries that also lower bad cholesterol to see if statins had extra superpowers.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 553 / 100
Quality score
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes—this means taking a statin isn't better than eating right or having surgery if they lower cholesterol the same amount.
- 2Lowering bad cholesterol by 1% lowered heart disease risk by about 1%, no matter if it was done with statins, diet, or surgery.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Journal of the American College of Cardiology
Year
2005
Authors
Jennifer G. Robinson, Brian J. Smith, N. Maheshwari, H. Schrott
Related Content
Claims (6)
Statins lower the amount of LDL cholesterol in the blood by blocking HMG-CoA reductase, an enzyme that produces cholesterol in the liver.
When statins lower LDL cholesterol, any additional reduction in heart disease risk comes only from that cholesterol lowering, not from other biological effects like reducing inflammation or preventing blood clots, when compared to non-statin methods that also lower LDL cholesterol.
For every 1% decrease in LDL cholesterol, coronary heart disease risk decreases by about 1% over five years, regardless of how the cholesterol was lowered or who the person is.
Reducing LDL cholesterol by 25-40% over five years lowers the chance of dying from coronary heart disease or having a heart attack by 20-35%, whether the reduction comes from statins, diet, surgery, or other treatments.
Statins improve heart health solely by lowering LDL cholesterol, so choosing a cholesterol-lowering drug should depend on how well it reduces LDL cholesterol, its safety, cost, and how well it is tolerated, not on unproven additional effects.
Lowering LDL cholesterol by 1 mmol/L over five years reduces the risk of ischemic stroke by 20%, regardless of whether the reduction is achieved with statins or other treatments, though data for non-statin treatments is sparse.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.